Connection

Mehul Suthar to Animals

This is a "connection" page, showing publications Mehul Suthar has written about Animals.
Connection Strength

0.236
  1. Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Curr Protoc Immunol. 2020 12; 131(1):e116.
    View in: PubMed
    Score: 0.027
  2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol. 2020 09 15; 94(19).
    View in: PubMed
    Score: 0.027
  3. Dynamics of Tissue-Specific CD8+ T Cell Responses during West Nile Virus Infection. J Virol. 2018 05 15; 92(10).
    View in: PubMed
    Score: 0.023
  4. Editorial overview: Viral immunology: Generating immunity to diverse viral pathogens. Curr Opin Virol. 2018 02; 28:viii-x.
    View in: PubMed
    Score: 0.022
  5. Taking the defensive: Immune control of Zika virus infection. Virus Res. 2018 08 02; 254:21-26.
    View in: PubMed
    Score: 0.022
  6. Negative regulators of the RIG-I-like receptor signaling pathway. Eur J Immunol. 2017 04; 47(4):615-628.
    View in: PubMed
    Score: 0.021
  7. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. PLoS One. 2021; 16(8):e0256482.
    View in: PubMed
    Score: 0.007
  8. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat Immunol. 2021 10; 22(10):1306-1315.
    View in: PubMed
    Score: 0.007
  9. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.007
  10. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung. Virology. 2021 10; 562:142-148.
    View in: PubMed
    Score: 0.007
  11. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
    View in: PubMed
    Score: 0.007
  12. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 2021 07 27; 36(4):109452.
    View in: PubMed
    Score: 0.007
  13. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 07 13; 36(2):109353.
    View in: PubMed
    Score: 0.007
  14. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.007
  15. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
    View in: PubMed
    Score: 0.007
  16. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
    View in: PubMed
    Score: 0.007
  17. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
    View in: PubMed
    Score: 0.007
  18. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.007
  19. Postnatal Zika virus infection is associated with persistent abnormalities in brain structure, function, and behavior in infant macaques. Sci Transl Med. 2018 04 04; 10(435).
    View in: PubMed
    Score: 0.006
  20. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. J Immunol. 2009 Nov 15; 183(10):6545-53.
    View in: PubMed
    Score: 0.003
  21. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med. 2006 Dec; 3(12):e525.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.